PFE · News · 20260914N

Patent Exclusivity Expiries

PFIZER INC · 2026-09-14 · Importance 38 · Surprise 24

Pfizer faces a patent cliff affecting key drugs, adding pressure to demand for established products. The reported loss of exclusivity risk is discussed together with declining COVID-19 product demand as a major commercial headwind. New products and pipeline launches are expected to become increasingly important in supporting growth from 2029.

Key facts

• A news headline identified Pfizer as facing a patent cliff as a major headwind. source